MedPath

Clinical Outcomes of Two Symmetrical Kera-rings Implantation in Grade Three Keratoconus

Not Applicable
Completed
Conditions
Cornea Ectasia
Interventions
Device: Intracorneal rings
Registration Number
NCT06498570
Lead Sponsor
Sohag University
Brief Summary

Clinical Outcomes of Two Symmetrical Kera-rings Implantation in Grade Three Keratoconus

Detailed Description

a retrospective non- randomized controlled clinical study. The study included twenty-three grade 3 keratoconic eyes of twenty-three patients, the keratoconus staging was based on Amsler-Krumeich classification The ICRS surgery was performed with the patient under topical anesthesia. A tunnel channel was created by femtosecond laser using a 60-kHz infrared neodymium glass femtosecond laser at a wavelength of 1053 nm (Abbott Laboratories Inc., Abbott Park, Illinois, USA). Two symmetrical kerarings (Mediphacos Inc., Belo Horizonte, Brazil), were implanted in all cases with 160° arc and 0.25, 0.30 mm according to corneal thickness in implantation site. After surgery, the patients had a full ocular evaluation on days 1, 7, and 14, and again after a month. For a period of 1-year, corneal topography readings were taken quarterly.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
23
Inclusion Criteria
  • stable keratoconus.
  • corneal cross-linking performed at least 6 months.
  • contact lens intolerance
  • minimum corneal thickness of 350 μm at the thinnest point (TP)
  • mean keratometry (K mean) value less than 59 D
Exclusion Criteria
  • any other associated ocular or systemic pathology could affect the vision.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
grade 3 keratoconic eyes Grade 3 eyes with stable keratoconusIntracorneal ringsgrade 3 keratoconic eyes Grade 3 eyes with stable keratoconus
Primary Outcome Measures
NameTimeMethod
K1 and K2 post-operative by Pentacamone year

Flat and Steep K in Diopter post ring implantation

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Elshimaa A.Mateen

🇪🇬

Sohag, Egypt

© Copyright 2025. All Rights Reserved by MedPath